There are also reports that describe occurrence of HCC in multidrug resistance 3 protein (MDR 3) protein deficiency, tight junction protein 2 (TJP2) deficiency, and transaldolase (TALDO) deficiency [187,188,189,190]. This evidence concerns the gene TALDO1 and hepatocellular carcinoma.